It’s not difficult to come across start-ups and young companies in the capital region. Berlin-Brandenburg boasts a diverse and steadily growing start-up ecosystem. And financing options are just as diverse as this ecosystem, encompassing various…
With the help of 3D printing, many things are now possible that were unthinkable just a few years ago: personalized, root-analog implants in dentistry, a vascularized, patient-specific organ model or a star sensor with integrated thermal expansion…
Eckert & Ziegler (ISIN DE0005659700, TecDAX) has signed a supply agreement with SK Biopharmaceuticals, a biotech company specializing in research, development, and commercialization of treatments of central nervous system (CNS) disorder, active in…
For the first time, a birth notification was transmitted fully digitally to a civil registry office—directly and machine-readably into the system used to record births.
This marks the digital breakthrough of a process that has remained largely…
An international research team led by scientists from Charité – Universitätsmedizin Berlin and Bern has identified a previously unknown function of the intestinal nervous system. As the team now reports in the journal Nature Immunology*, the…
The Einstein Foundation Berlin honors the Australian psychologist Simine Vazire, the Brazilian Reproducibility Initiative, and the project Erring Rigorously with the Einstein Foundation Award for Promoting Quality in Research 2025. The latter project…
This year, the international ranking of “Highly Cited Researchers” by the analysis company Clarivate lists fifteen scientists from Charité – Universitätsmedizin Berlin among the world’s most influential researchers.
Berlin-based voize has closed a $50 million Series A funding round led by London's Balderton Capital, with backing from HV Capital, Redalpine and Y Combinator. According to a press release from Balderton, the investment will fuel voize's European…
Captain T Cell has successfully completed a major financing round, securing a total of EUR 20 million to advance its next-generation TCR-T therapies. The round was led by several new investors, with existing backers also increasing their commitments.…
Researchers and end users jointly develop forward-looking health technologies with funding of €4 million
